GlassScriptPhysician profile
Bethany Wortman
NPI 1083875876
$2,247.09
in general payments reported to CMS, 2019-2025
25 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $531 · 2020: $336 · 2021: $218 · 2022: $248 · 2023: $305 · 2024: $382 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $914.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $497.87 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $314.77 | 2019-2025 | Veozah |
| Therapeuticsmd, INC. | $163.05 | 2020-2021 | |
| Hologic Sales and Service, LLC | $149.02 | 2023-2024 | Myosure Tissue Removal Device, Acessa Provu System, Aptima |
| Allergan, INC. | $113.93 | 2019 | |
| Sumitomo Pharma America, INC. | $108.13 | 2023-2024 | Myfembree |
| Pfizer INC. | $88.95 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.09 | 2019-2024 | |
| Sage Therapeutics, LLC | $77.27 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $63.80 | 2021-2022 | |
| Daiichi Sankyo INC. | $63.24 | 2019-2021 | |
| Davol INC. | $61.34 | 2021-2024 | Arista Ah Flexitip |
| Currax Pharmaceuticals LLC | $59.56 | 2020 | |
| Cranial Technologies, INC | $58.72 | 2023-2025 | Doc Band |
| Exeltis, USA INC. | $54.73 | 2020-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $47.80 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $44.44 | 2021-2022 | |
| Exact Sciences Corporation | $43.80 | 2024 | Cologuard Collection Kit |
| Minerva Surgical, INC | $43.18 | 2022 | |
| Merck Sharp & Dohme LLC | $28.96 | 2019 | |
| Supernus Pharmaceuticals, INC. | $22.55 | 2025 | Qelbree |
| Coopersurgical, INC. | $18.93 | 2025 | Paragard T 380a |
| Avion Pharmaceuticals | $12.69 | 2019 | |
| Amgen INC. | $11.35 | 2020 | |
| Organon LLC | $10.92 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bethany Wortman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.